Immuneering Corp
Public company- Headquarters
- CAMBRIDGE, Massachusetts
- Ticker
- IMRX
- CIK
- 0001790340
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Nov 9, 2026
Executive appointmentClass III Director appointed: Grant C. Bogle, MBA
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class III DirectorGrant C. Bogle, MBA | Nov 9, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
COO appointed: Tara L. Kieffer, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
director appointed: Robert J. Spiegel, M.D.
- GeoVax Labs, Inc.
director appointed: Shahin Behroyan
- Executive appointment
Class III Director appointed: Grant C. Bogle, MBA
Grant C. Bogle, MBA was named Class III Director of Immuneering Corp, effective November 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Nov 9, 2026Role: Class III Director
Only one public record so far. We add events as soon as a new filing lands; watch Immuneering Corp to get them in your digest.
Last verified Nov 10, 2026